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Abstract: A high body mass (BMI) index has repeatedly been associated with non-atopic asthma,
but the biological mechanism linking obesity to asthma is still poorly understood. We aimed to test
the hypothesis that inflammation and/or innate immunity plays a role in the obesity-asthma link.
DNA methylome was measured in blood samples of 61 non-atopic participants with asthma and
146 non-atopic participants without asthma (non-smokers for at least 10 years) taking part in the
Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) study.
Modification by DNA methylation of the association of BMI or BMI change over 10 years with
adult-onset asthma was examined at each CpG site and differentially methylated region. Pathway
enrichment tests were conducted for genes in a priori curated inflammatory pathways and the
NLRP3-IL1B-IL17 axis. The latter was chosen on the basis of previous work in mice. Inflammatory
pathways including glucocorticoid/PPAR signaling (p = 0.0023), MAPK signaling (p = 0.013), NF-κB
signaling (p = 0.031), and PI3K/AKT signaling (p = 0.031) were enriched for the effect modification
of BMI, while NLRP3-IL1B-IL17 axis was enriched for the effect modification of BMI change over
10 years (p = 0.046). DNA methylation measured in peripheral blood is consistent with inflammation
as a link between BMI and adult-onset asthma and with the NLRP3-IL1B-IL17 axis as a link between
BMI change over 10 years and adult-onset asthma in non-atopic participants.
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1. Introduction
Obesity and overweight have repeatedly been linked to asthma [1,2], with several studies
reporting a stronger association of obesity or overweight with non-atopic compared to atopic
asthma [3,4] and with late-onset asthma compared to early-onset asthma [5,6]. We previously observed
heterogeneity of the overweight-asthma association across asthma classes identified by latent class
analysis [7].
The biological mechanism linking obesity and overweight with asthma is poorly understood.
Excessive adipose tissue may increase the work associated with breathing, reduce lung volume,
and promote airway hyperresponsiveness and airway narrowing [8,9]. However, the more likely
hypothesis is that this association is not entirely mechanical, but that chronic inflammation
related to overweight and obesity contributes to asthma development. Adiposity is characterized
by dysregulated production of pro-inflammatory cytokines and infiltration and activation of
macrophages [10,11]. While M2 macrophages are predominant in non-obese adipose tissue,
pro-inflammatory M1 macrophages increase in obese adipose tissue, leading to low-grade chronic
systemic inflammation [12]. Whether and how obesity and overweight leads to airway inflammation is
controversial. An interesting finding in mice experiments pointed to NLRP3 (nucleotide-binding
domain, leucine-rich repeats-containing family, pyrin domain-containing-3) inflammasome and
interleukin-17 (IL17) producing innate lymphoid cell group 3 (ILC3) cells as a link between obesity
and airway hyperresponsiveness (AHR) [13]. Upon recognition of various danger signals, NLRP3
inflammasome produces interleukin-1β (IL1B) via caspase-1. IL1B, in turn, activates ILC3 cells to
produce IL17, leading to AHR. Kim and her colleagues demonstrated that the NLRP3-IL1B-IL17 axis is
crucial in AHR development in obese mice [13].
High-throughput arrays allow cost-effective genome-wide quantification of DNA methylation.
The epigenome-wide association study (EWAS) design has been successfully applied to identify
methylation markers measured in peripheral blood related to a variety of endogenous and
environmental insults as well as health outcomes. Recently, the largest EWAS on asthma identified
DNA methylation at several immunity and inflammation related CpG sites to be associated with
asthma in children [14–16]. Several studies reported methylation markers of obesity and overweight
measured in peripheral blood, which in part reflected inflammatory pathways [17–19]. Rastogi and
her colleagues reported differential DNA methylation in obese children with non-atopic asthma that
was consistent with a role of inflammation [20]. However, differential DNA methylation related
to obesity-associated asthma in adults is largely unexplored. An earlier EWAS study in adults
showed heterogeneity in differential DNA methylation patterns across inflammatory sub-phenotypes
of asthma [21].
In light of the suggestive evidence for inflammation as a mediator in the overweight/
obesity-asthma link, we formally explored whether interaction signals between body mass index
(BMI) or BMI change and DNA methylation in peripheral blood on non-atopic adult-onset asthma
are enriched for signals mapping to inflammatory pathways. Specifically, we tested the hypothesis by
conducting an epigenome-wide interaction study (EWIS) followed by candidate pathway enrichment
analysis for a priori curated inflammatory pathways and the NLRP3-IL1B-IL17 axis, making use of the
information from the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults
(SAPALDIA). Identification of differential DNA methylation enriched in the candidate pathways would
add further support that inflammation and/or innate immunity play a role in overweight-asthma
link, although the inflammation was not directly measured. This hypothesis-driven approach was
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corroborated by agnostic pathway enrichment analysis in combination with differentially methylated
region (DMR) analysis.
2. Materials and Methods
2.1. Study Samples
The Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults was initiated in
1991 (SAPALDIA1), recruiting 9651 participants in eight regions representing various meteorological
and geographical environments in Switzerland. Of the 9651 participants, 8047 and 6088 were
followed-up in the second and the third survey, respectively (SAPALDIA2 in 2001–3 and SAPALDIA3
in 2010–11). The detailed study protocol was reported previously [22,23].
We conducted a nested case-control study of adult-onset asthma among the non-atopic
SAPALDIA3 participants, all of whom were non-smokers for at least 10 years before blood draw
and interview. Cases were selected among the participants with self-reported asthma and self-reported
age of onset later than 16 years based on the availability of archived blood samples and covariate
information. Controls were randomly selected among the participants who never reported the
following throughout the surveys: self-reported asthma, physician-diagnosed asthma, asthma attack
in the last 12 months, current asthma medication, wheezing without cold in the last 12 months, three
or more asthma-related symptoms in the last 12 months (symptoms considered: breathless while
wheezing, woken up with a feeling of chest tightness, attack of shortness of breath after exercise, attack
of shortness of breath while at rest, woken by attack of shortness of breath). Cases and controls with
positive skin prick test at baseline defined as an adjusted mean wheal diameter ≥3 mm to at least
one of eight common respiratory allergens were excluded (allergens considered: cat fur, dog epithelia,
house dust mite (Dermatophagoides pteronyssinus), timothy grass pollen, birch pollen, Parietaria pollen,
and the molds Alternaria and Cladosporium). In total, 61 cases and 146 controls were examined in the
EWIS followed by the pathway enrichment tests. Study samples’ characteristics are summarized in
Table 1. All participants gave written informed consent, and ethical approval was obtained from the
Swiss Academy of Medical Sciences and the regional committees for each study center.
Table 1. Study samples’ characteristics by adult-onset asthma status at the Swiss Cohort Study on Air
Pollution and Lung and Heart Diseases in Adults 2010–11 (SAPALDIA3).
Cases Controls
N 61 146
Age (year) 60.8 (15.6) 57.4 (15.0)
Female 43 (70%) 82 (56%)
BMI (kg/m2) a 25.7 (5.8) 24.5 (4.8)
BMI change (kg/m2) b 0.4 (2.0) 0.5 (1.6)
Smoking c
Former 27 (44%) 50 (34%)
Never 34 (56%) 96 (66%)
Pack-years d 7.8 (13.3) 6.8 (11.6)
Education level e
Low 0 (0%) 2 (1%)
Middle 43 (70%) 94 (64%)
High 18 (30%) 50 (34%)
Physical activity f
Insufficiently active 18 (30%) 30 (21%)
Sufficiently active 42 (69%) 113 (77%)
N/A 1 (2%) 3 (2%)
Bench time (min) g 80.0 (34.0) 82.5 (32.5)
hs-CRP (mg/L) h 1.3 (1.4) 0.7 (1.2)
Data are presented as count (%) or median (interquartile range). a Measured at SAPALDIA3. b Change in body
mass index (BMI) between SAPALDIA 2001–3 (SAPALDIA2) and SAPALDIA3. c Former smokers had not smoked
for at least 10 years before blood was drawn. d Only computed in former smokers (pack-years were set to zero for
never smokers). e Low = primary school; middle = secondary/middle school or apprenticeship; high = college
or university. f Sufficiently active at SAPALDIA3 = either moderate physical activity ≥ 150 min/week, vigorous
physical activity ≥ 60 min/week, or combined duration (duration of moderate physical activity + 2 × duration of
vigorous physical activity) ≥ 150 min/week; insufficiently active = otherwise. N/A = not available. g Time elapsed
between blood draw and storage in freezer. h Measured at SAPALDIA2.
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2.2. Covariates
Weight and height were measured, and BMI was computed as weight in kilograms divided
by the square of height in meters. BMI change was defined as the difference in BMI between
SAPALDIA3 and SAPALDIA2. Negative values of the BMI change mean reduction in BMI. Educational
level was categorized from self-reported highest education into “low” (primary school), “middle”
(secondary/middle school or apprenticeship), and “high” (college or university). Pack-years of
cigarettes smoked in life were computed from self-reported number of cigarettes smoked per day and
smoking history. Physical activity was dichotomized from self-reported frequency and duration of
moderate and vigorous physical activity into “sufficiently active” [either moderate physical activity ≥
150 min/week, vigorous physical activity≥ 60 min/week, or combined duration (duration of moderate
physical activity + 2 × duration of vigorous physical activity) ≥ 150 min/week] and “insufficiently
active” (otherwise).
In order to confirm that BMI is related to chronic inflammation, we examined the association
between BMI and high-sensitive C-reactive protein (hs-CRP) within the study subjects (n = 206;
one subject was excluded due to missing information on hs-CRP). We used information on both BMI
and hs-CRP at SAPALDIA2 because hs-CRP was measured only at SAPALDIA2. Log-transformed
hs-CRP was regressed on BMI after adjustment for age, sex, education level, study area, and pack-years
of cigarettes smoked up to SAPALDIA2.
2.3. Methylome
Peripheral blood samples had been collected at SAPALDIA3, the second follow-up visit in 2010 of
the cohort study. Pre-analytically, the blood samples were processed, and the buffy coat fraction was
archived at −80 ◦C for five years until DNA extraction using the QIAamp Blood Mini Kit (QIAGEN,
Hilden, Germany) following the manufacturer’s instructions [24]. A small number of samples yielded
limited DNA quantity and were replaced by DNA extracted [using the Gentra Puregene Blood Kit
(QIAGEN, Hilden, Germany) following the manufacturer’s instructions] from whole blood of the same
venipuncture used for buffy coats. Bisulfite conversion of 600 ng of each sample was performed using
the EZ-96 DNA Methylation-Gold™ Kit according to the manufacturer’s protocol (Zymo Research,
Orange, CA, USA). Then, 200 ng of bisulfite-converted DNA was used for hybridization on the
Illumina Infinium HumanMethylation450 BeadChip (Illumina, San Diego, CA, USA) following the
Illumina Infinium HD Methylation protocol. Each array consisted of 96 samples distributed equally
among 8 chips. The arrays were designed such that batch effects (e.g., sample position and intra-
and inter-variability in arrays and chips) did not completely confound with biological covariates.
This design allowed the retention of biological variation (including the variable of interest) after
correction for technical variation. Specifically, each chip incorporated proportional amounts of samples
representing the different centers, confounding factors, and cases-control status. Cases and controls
were also placed on the chips (not following a specific sequence) in order to minimize technical
variation between them. Raw fluorescence intensities were retrieved and preprocessed using the
R package “minfi” [25]. One sample with sex mismatch was excluded. Background correction and
dye bias correction were performed using Noob (normal-exponential out-of-band) procedure [26].
DNA methylation levels were expressed as β values, defined as the ratio of methylated intensity over
total intensity with offset = 100. β values were set to missing if the detection p-value was higher
than 10−16. Probes on sex chromosome were excluded. Probes were then filtered by call rate <0.95.
All samples had call rate >0.95. Beta-mixture quantile normalization (BMIQ) procedure was conducted
to correct for the Illumina probe design bias [27]. The probes known to hybridize with multiple
genomic locations or to target CpG sites overlapping known SNPs with minor allele frequency greater
than 1% in Europeans were excluded [28]. Finally, 430,591 CpGs were ready for analysis. In addition,
principal component analysis (PCA) was conducted on the 220 control probes incorporated on the
Illumina chip following Lehne and Drong [29], and β values were regressed on the first 30 components.
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All of the statistical analyses used the resulting residuals in place of the β values to account for
batch effects.
2.4. EWIS of DNA Methylation and BMI on Adult-Onset Asthma
Logistic regression models were fitted for adult-onset asthma status on BMI at SAPALDIA3,
residual of the β value at each CpG site, and their multiplicative interaction upon adjustment for age
(in years), sex, education level, study area, pack-years of cigarettes smoked in life, bench time (in
minutes), and Houseman estimates [30] of white blood cell composition for B cells, CD4 T cells, CD8 T
cells, natural killer cells, monocytes, and eosinophils.
Asthma ∼ BMI × Residuali + Age + Sex + Education + Area + Packyear + Benchtime + Bcell
+CD4T + CD8T + NK + Mono + Eos (i = 1, . . . , 430591)
We did not adjust for neutrophils because immune response in non-atopic participants was
possibly driven by neutrophil proliferation [31,32], and therefore adjustment for neutrophils could
obscure the association of interest. Despite the female preponderance in cases compared to controls
(Table 1), we did not consider stratification or effect modification by sex based on our observation
that the association between BMI and non-atopic adult-onset asthma did not differ by sex (Table S3).
The interaction was considered genome-wide significant when the p-value from the interaction term
was smaller than 0.1 after the Benjamini-Hochberg correction for multiple testing. As a sensitivity
analysis, the same EWIS was repeated after further adjustment, either for physical activity or for
neutrophil estimates.
2.5. EWIS of DNA Methylation and BMI Change on Adult-Onset Asthma
Logistic regression models were fitted for adult-onset asthma status on BMI change, residual of
the β value at each CpG site, and their multiplicative interaction after adjustment for the same set of
covariates as above and additionally for BMI at SAPALDIA2.
Asthma ∼ (BMIS3 − BMIS2)× Residuali + BMIS2 + Age + Sex + Education + Area + Packyear
+Benchtime + Bcell + CD4T + CD8T + NK + Mono + Eos (i = 1, . . . , 430591)
The same sensitivity analyses were conducted as above.
2.6. Candidate Pathway Enrichment Analyses Using Weighted Kolmogorov-Smirnov (WKS) Method
Genes relevant to the NLRP3-IL1B-IL17 axis were curated based on Kim et al. [13].
Inflammation-related genes were curated previously by Loza et al. into 17 mutually exclusive
pathways [33]. The complete list of the genes assigned to each pathway can be found in Table S1.
CpG sites were then assigned to the pathway if the CpG sites resided within 200 bp upstream or
downstream of the genes included in each pathway.
We tested if the pathways were over-represented in the EWIS results by applying the Weighted
Kolmogorov-Smirnov (WKS) enrichment test [34]. Using this algorithm, the absolute Z-statistics
of the CpG sites assigned to each pathway (e.g., 219 CpG sites assigned to NLRP3-IL1B-IL17 axis)
were compared with the null distribution created by 10,000 Monte-Carlo simulations of the absolute
Z-statistics from the entire 430,591 CpG sites. In this approach, Z-statistics from all CpGs mapped to a
pathway were compared to the null distribution without selection based on EWIS-derived p-values.
Over-representation of the pathway was determined by Kolmogorov-Smirnov tests. Pathways with
WKS p-value < 0.05 were declared as enriched. The procedure included permutation-based multiple
testing correction [34,35].
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2.7. Identification of Differentially Methylated Regions (DMR)
We used the R package DMRcate to identify DMRs [36]. The Z-statistics from EWIS were squared
and smoothed using a Gaussian kernel with a bandwidth of 1000 bp and scaling factor of 2, which is
equivalent to the kernel standard deviation of 500 bp. p-values were computed for each CpG site by
comparison to the null distribution of the smoothed estimates. The regions containing at least one CpG
site with Benjamini-Hochberg adjusted p-value < 0.05 were declared as significant. The significant
DMRs were annotated to the genes whose promoter region, defined as 2000 bp from the transcription
start site, overlapped with the DMRs.
2.8. Agnostic Pathway Enrichment Analyses Using Ingenuity Pathway Analysis (IPA)
The 1305 genes annotated to the 1131 DMRs identified as significant effect modification of BMI
on adult-onset asthma were tested for over-representation using Ingenuity Pathway Analysis (IPA)
(http://www.ingenuity.com/; QIAGEN, Redwood City, CA, USA) canonical pathway analysis. In brief,
the maximum effect modification estimate and the minimum Benjamini-Hochberg adjusted p-value for
each DMR were assumed to represent the expression level and the p-value, respectively, for the gene
annotated to the DMR. The DMRs annotated multiple genes constituted multiple entries and each
annotated a single gene. The DMRs with no gene annotation were excluded (n = 114). The 20 genes
annotated to the 18 DMRs for BMI change were too few to conduct the same pathway analysis.
3. Results
From association analysis using SAPALDIA2 information, we confirmed a positive association
between BMI and hs-CRP. One unit increase in BMI was associated with 0.1 unit increase in
log-transformed hs-CRP (95% confidence interval [0.07, 0.14]; p < 10−8). We conducted an EWIS
of DNA methylation and BMI or BMI change over 10 years on adult-onset asthma among non-atopic,
non-smoking SAPALDIA3 participants (Table 1). We found no epigenome-wide significant effect
modification after multiple testing corrections. Sensitivity analyses with additional adjustment for
physical activity or neutrophil estimates also resulted in no epigenome-wide significant CpG sites.
Figures 1, 2, and Figures S1–S4 summarize the EWIS results.
After pathway enrichment analysis of 17 a priori curated inflammatory pathways [33], we found
an over-representation of effect modification by DNA methylation of BMI on adult-onset asthma
in several pathways: Glucocorticoid/PPAR (peroxisome proliferator-activated receptor) signaling,
MAPK (mitogen-activated protein kinase) signaling, NF-κB (nuclear factor kappa-B) signaling, and
PI3K/AKT (phosphatidylinositol-3-kinases/protein kinase B) signaling (Table 2). The pathway
“global inflammation”, defined as the entirety of the 1027 genes assigned to the 17 inflammation
pathways, also showed enrichment. In the sensitivity analyses, the enrichment of PI3K/AKT signaling
disappeared after adjustment for physical activity, while the enrichment of NF-κB signaling and
PI3K/AKT signaling disappeared after adjustment for neutrophil estimates (Table 2).
When the EWIS was conducted using BMI change instead of BMI, NLRP3-IL1B-IL17 axis and
global inflammation were enriched (Table 3). No enrichment was found after additional adjustment
for physical activity. Global inflammation remained enriched after adjustment for neutrophil estimates,
while the NLRP3-IL1B-IL17 axis did not. Tables 2 and 3 summarize the WKS enrichment test results.
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BMI, residuals of DNA methylation at a single CpG site, and their multiplicative interaction upon 
adjustment for age, sex, education level, study area, pack-years of cigarettes smoked in life, bench 
time, and white blood cell composition estimates for B cells, CD4 T cells, CD8 T cells, natural killer 
cells, monocytes, and eosinophils. The CpGs assigned to the pathway enriched with p < 0.05 are 
highlighted in colors. No line of significance was drawn, as no CpG reached genome-wide 
significance after multiple testing corrections. 
Figure 1. Volcano plot from the epigenome-wide interaction study (EWIS) of DNA methylation and
BMI on adult-onset asthma. The EWIS fitted logisti egression models of adult-onset asthma on
BMI, residuals of DNA methylation at a single CpG site, and their multiplicative interaction upon
adjustment for age, sex, education level, study area, pack-years of cigarettes smoked in life, bench
time, and white blood cell composition estimates for B cells, CD4 T cells, CD8 T cells, natural killer
cells, monocytes, and eosinophils. The CpGs assigned to the pathway enriched with p < 0.05 are
highlighted in colors. No line of significance was drawn, as no CpG reached genome-wide significance
after multiple testing corrections.
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Figure 2. Volcano plot from the EWIS of DNA methylation and BMI change on adult-onset asthma.
The EWIS fitted logistic r gression models of adult-o t asthma on BMI change, residuals of DNA
methylation at a single CpG site, and their multiplicative interaction upon adjustment for age, sex,
education level, study area, pack-years of cigarettes smoked in life, bench time, and white blood
cell composition estimates for B cells, CD4 T cells, CD8 T cells, natural killer cells, m nocytes, and
eosinophils. The CpGs assigned to the pathway enriched with p < 0.05 are highlighted in colors.
No line of significance as drawn, as no CpG reached genome-wide significance after multiple
testing corrections.
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Table 2. EWIS of DNA methylation and BMI on adult-onset asthma. Enrichment test results for 17
inflammation pathways and NLRP3-IL1B-IL17 axis.
Pathway #Genes #CpGs
Enrichment p-Value
Basic Model
Adjusted for
Physical
Activity
Adjusted for
Neutrophil
Counts
Adhesion-extravasation-migration 142 1737 0.48 0.30 0.37
Apoptosis signaling 68 1210 0.22 0.34 0.32
Calcium signaling 14 413 0.81 0.72 0.70
Complement cascade 40 483 0.92 0.73 0.96
Cytokine signaling 172 1883 0.070 0.053 0.067
Eicosanoid signaling 39 450 0.58 0.78 0.55
Glucocorticoid/PPAR signaling 21 404 0.0023 0.0053 0.0039
G-Protein coupled receptor signaling 42 1133 0.74 0.49 0.66
Innate pathogen detection 50 515 0.89 0.72 0.88
Leukocyte signaling 121 1429 0.14 0.059 0.090
MAPK signaling 118 2682 0.013 0.0036 0.018
Natural killer cell signaling 31 368 0.54 0.41 0.51
NF-κB signaling 33 654 0.031 0.0028 0.054
Phagocytosis-Ag presentation 39 1058 0.81 0.72 0.66
PI3K/AKT signaling 37 907 0.031 0.23 0.053
ROS/glutathione/cytotoxic granules 22 190 0.58 0.45 0.53
TNF superfamily signaling 38 537 0.78 0.69 0.73
Global inflammation § 1027 15985 0.0026 0.011 0.0057
NLRP3-IL1B-IL17 axis 11 219 1.00 0.99 1.00
The basic model regressed adult-onset asthma on BMI, residuals of DNA methylation at a single CpG site, and their
multiplicative interaction upon adjustment for age, sex, education level, study area, pack-years of cigarettes smoked
in life, bench time, and white blood cell composition estimates for B cells, CD4 T cells, CD8 T cells, natural killer cells,
monocytes, and eosinophils. § Total of the 17 inflammation pathways; the number of CpG in this pathway (15,985)
is smaller than the sum of the CpGs assigned to 17 pathways because there are CpGs assigned to multiple pathways,
although the 17 pathways are mutually exclusive at gene level. Enrichment p-values are in bold if p < 0.05.
Table 3. EWIS of DNA methylation and BMI change on adult-onset asthma: enrichment test results for
17 inflammation pathways and NLRP3-IL1B-IL17 axis.
Pathway #Genes #CpGs
Enrichment p-Value
Basic Model
Adjusted for
Physical
Activity
Unadjusted
for Neutrophil
Counts
Adhesion-extravasation-migration 142 1737 0.67 0.60 0.39
Apoptosis signaling 68 1210 0.50 0.37 0.22
Calcium signaling 14 413 0.29 0.34 0.21
Complement cascade 40 483 0.45 0.64 0.34
Cytokine signaling 172 1883 0.26 0.35 0.21
Eicosanoid signaling 39 450 0.48 0.17 0.61
Glucocorticoid/PPAR signaling 21 404 0.063 0.15 0.072
G-Protein coupled receptor signaling 42 1133 0.47 0.88 0.46
Innate pathogen detection 50 515 0.059 0.12 0.13
Leukocyte signaling 121 1429 0.35 0.49 0.34
MAPK signaling 118 2682 0.13 0.33 0.24
Natural killer cell signaling 31 368 0.91 0.75 0.91
NF-κB signaling 33 654 0.70 0.49 0.62
Phagocytosis-Ag presentation 39 1058 0.51 0.89 0.71
PI3K/AKT signaling 37 907 0.98 0.98 0.89
ROS/glutathione/cytotoxic granules 22 190 0.24 0.55 0.14
TNF superfamily signaling 38 537 0.085 0.33 0.065
Global inflammation § 1027 15985 0.048 0.23 0.028
NLRP3-IL1B-IL17 axis 11 219 0.046 0.13 0.15
The basic model regressed adult-onset asthma on BMI change, residuals of DNA methylation at a single CpG
site, and their multiplicative interaction upon adjustment for BMI at SAPALDIA2, age, sex, education level, study
area, pack-years of cigarettes smoked in life, bench time, and white blood cell composition estimates for B cells,
CD4 T cells, CD8 T cells, natural killer cells, monocytes, and eosinophils. § Total of the 17 inflammation pathways;
the number of CpG in this pathway (15,985) is smaller than the sum of the CpGs assigned to 17 pathways because
there are CpGs assigned to multiple pathways, although the 17 pathways are mutually exclusive at gene level.
Enrichment p-values are in bold if p < 0.05.
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Our study was likely underpowered to identify differential methylation markers from the
EWIS approach considering the large dimension of the methylome data, the relatively small sample
size, and the investigation of effect modification instead of main effects. Acknowledging these
issues, we additionally searched for differentially methylated regions (DMR) using the R package
DMRcate [36]. Based on the EWIS, we identified 1131 DMRs that modify the association of BMI with
non-atopic asthma as well as 18 DMRs that interact with BMI change, affecting its association with
non-atopic asthma. Figures 3 and 4 summarize the DMRs. Each circle represents one DMR whose x-
and y-coordinates depict maximum effect modification by 1 SD increase in residuals within the region
and minimum Benjamini-Hochberg adjusted p-value within the region, respectively. The 1131 and 18
DMRs were annotated to 1305 and 20 genes, respectively, and there were two overlapping genes. In
an agnostic pathway enrichment analysis, using IPA, we found PPARα/RXRα (retinoid X receptor
alpha) activation (p = 0.015), ERK (extracellular-regulated kinase) /MAPK signaling (p = 0.038), and
glucocorticoid receptor signaling (p = 0.038), among others, enriched for the 1305 genes annotated to
the 1131 DMRs. Figure S5 and Table S2 summarize the IPA pathway analysis results.
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We found no single CpG sites of genome-wide significant effect modification. However, we did
find DMRs and pathway nrichments. DNA ethylation markers usually act in concert at n ighboring
CpG sites [37,38], therefore EWIS alone may fail to iden if true differential methylation markers [39].
Global inflammation, defined as th entirety f the 1027 inflammation-related genes according
to the classification proposed by Loza et al. [33], was over-represented in the DNA methylation
signals modifying the BMI-adult-onset asthma ass ciation. The gnostic search for th pathway
enrichment of the DMRs als r vealed several relevant pathways. Our tudy results are consistent wi h
inflammation modifying the effect of BMI on adult-onset non-atopic sthma. Adiposity is believed to
induce chronic systemic inflammation via dysregu ated production of pro-inflamma ory cytokines
and immune cells infiltrated into adipose tissue [11,40]. Our findings suggest that al ered methylation
in pro-inflammatory gene networks potentially mediate the link between overweight and non-atopic
adult-onset sth a. This is in line with previous find ngs in children. Rastogi and h r colleagues
reported hypomethylation in the promoter of genes involved in innate immunity and n n-atopic
inflammation in obese children with asthma [20].
Amon the 17 inflam ation pathways curated by Loza and his colleagues [33],
glucocorticoid/PPAR signal g showed the strongest enrichment. The agnostic search for the pathway
enrichment in the DMRs also found enrichment of Glucocorticoid receptor signaling in addition
to PPARα/RXRα activat o . The glucocorticoid/PPAR signaling includes the genes coding for the
nuclear rec ptors for glucocorticoid , PPARs, and associated proteins. PPARs have been associated
with asthma, and PPA agonists are being considered as a new asthma treatme t [41]. While w cannot
rule out the possibility that asthma medi ation led to DNA methylation on the genes invol d in
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glucocorticoid receptor signaling, it is not likely that this would explain the interaction of methylation
signals in this pathway with BMI or BMI change.
MAPK signaling, NF-κB signaling, and PI3K/AKT signaling are all involved in signal
transduction downstream to the detection of insults, e.g., by TLR (toll-like receptor). The enrichment
signals for PI3K/AKT signaling disappeared when the model was additionally adjusted for physical
activity, suggesting that the effect modification of BMI on adult-onset asthma might be confounded
or mediated by physical activity. The enrichment of NF-κB signaling and PI3K/AKT signaling
disappeared when the model was further adjusted for neutrophil estimates, suggesting that the effect
modification in this pathway might be modulated by neutrophil proliferation and hence disguised
by the adjustment for neutrophil estimates. ERK/MAPK signaling was also over-represented in the
DMRs from the agnostic pathway analysis.
Interestingly, NLRP3-IL1B-IL17 axis was enriched in the EWIS using BMI change, suggesting that
BMI change represents a phenotype distinct from BMI. The well-known limitation of BMI is that it
cannot distinguish fat from lean mass. Weight change in late adulthood is more likely attributable to
change in fat than in lean mass [42], and people tend to lose lean mass while aging [43,44]. Therefore,
fat composition could be better reflected in BMI change than in BMI. Our finding that the enrichment
of NLRP3-IL1B-IL17 axis disappeared upon adjustment for neutrophil estimates is consistent with the
growing evidence of IL17 playing a role in recruitment, accumulation, and survival of neutrophils in
asthma [31,32].
The NLRP3 inflammasome and downstream activity have been associated with both asthma [45]
and obesity [46] in humans. To the best of our knowledge, however, this study is the first to provide
evidence of the NLRP3-IL1B-IL17 axis as a link between overweight and non-atopic adult-onset asthma
in humans. This study is also the first to provide evidence that inflammation represented in the DNA
methylation profile may play a role in the link between overweight and non-atopic adult-onset asthma.
Pathway enrichment analyses have often been applied to interpret genome-wide patterns of
differential methylation. Widely used tools for pathway enrichment analyses include GSEA (gene
set enrichment analysis) [47], DAVID (the database for annotation, visualization, and integrated
discovery) [48], and IPA (http://www.ingenuity.com; QIAGEN, Redwood City, CA, USA), which
were originally developed to analyze differential expression of genes. In order to apply these tools to
epigenetics, differential methylation signals first need to be translated from CpGs to genes. This can
lead to a bias, e.g., that large genes with multiple CpGs are more likely to be represented. In this
study, we applied the WKS method to test pathway enrichment of the EWIS results. The WKS
method works in a similar way as GSEA, but the enrichment is quantified using CpG (and not
gene) level statistics. This method also supports examination of custom-curated pathways, allowing
straightforward interpretation.
We were underpowered to identify differential DNA methylation as effect modifiers, although the
problem was partly overcome by applying integrative approaches, i.e., DMR and pathway enrichment
analysis. The fact that DMR analysis resulted in more than 1000 signals while EWIS identified
no signals indicates that a multivariate approach is better suited than an univariate approach to
study epigenetic marks that function in clusters. We applied the WKS enrichment analyses to the
absolute Z-statistics. Therefore, the direction of the effect modification, meaning whether hypo- or
hyper-methylation was associated with increased effect of BMI, was not taken into consideration.
The IPA pathway analysis results may have been biased by transforming the DMRs into gene-level
statistics. Moreover, we annotated CpG sites simply based on the location regardless of their functional
information, i.e., whether they resided in promoter, gene body, or intergenic region, CpG islands or
not, etc. The cross-sectional design of our study along with the effect modification being studied
without mediation analysis prevents inference of causal mediation. However, our findings of the
enriched pathways using BMI change cannot be driven entirely by reverse causality because BMI
change preceded the DNA methylation measurements. Given the recent Mendelian randomization
studies that reported a causal effect of BMI on childhood asthma [49] and a causal effect of BMI on
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lifetime asthma [50], the overweight-asthma association may potentially be causal. In this study, we
observed differential DNA methylation enriched in inflammatory pathways but did not measure
chronic inflammation directly in the study subjects. However, we confirmed that the study subjects
showed a strong positive association between BMI and hs-CRP at SAPALDIA2. In order to elucidate
if overweight-induced inflammation causes asthma, further studies, including two-step Mendelian
randomization studies, are warranted. Taking transcriptomics and proteomics study of blood, lung,
and adipose tissue with asthma phenotype heterogeneity into consideration will be crucial.
5. Conclusions
DNA methylation measured in peripheral blood is consistent with inflammation as a potential
link between BMI and adult-onset asthma and with the NLRP3-IL1B-IL17 axis as a potential link
between BMI change over 10 years and adult-onset asthma in non-atopic non-smokers.
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